Edinburgh Biosciences offers design, development, manufacture, sales, and support of optoelectronic components for biomedical markets.
Edinburgh Biosciences has raised $3.1M in total funding. The most recent round was Debt Financing. The last funding was announced in April 2025.
Edinburgh Biosciences's investors include Contamac, Innofield Biotechnology.
Edinburgh Biosciences is headquartered in Livingston, United Kingdom.
Edinburgh Biosciences offers design, development, manufacture, sales, and support of optoelectronic components for biomedical markets.
Edinburgh Biosciences is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Edinburgh Biosciences — Funding & Investors." VCBacked, April 29, 2025, https://www.vcbacked.co/company/edinburgh-biosciences. Accessed August 14, 2026.
VCBacked. (2025). Edinburgh Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/edinburgh-biosciences
{{cite web |title=Edinburgh Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/edinburgh-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated